TAZID 2g IV Price

Overview

Welcome to Dwaey, specifically on TAZID 2g IV Injection/Powder for page.
This medicine contains an important and useful components, as it consists of Ceftazidime.
TAZID 2g IV is available in the market in concentration 2g/Vial and in the form of Injection/Powder for.

ALKEM LABORATORIES LIMITED is the producer of TAZID 2g IV and it is imported from INDIA, The most popular alternatives of TAZID 2g IV are listed downward .

Mode Of Action

Ceftazidime binds to one or more of the penicillin-binding proteins (PBPs) which inhibits the final transpeptidation step of peptidoglycan synthesis in bacterial cell wall, thus inhibiting biosynthesis and arresting cell wall assembly resulting in bacterial cell death.

Indication

• Pneumonia
• Cystic fibrosis
• Bacterial septicemia
• Meningitis
• Peritonitis
• Skin and Skin-Structure Infections
• Endometritis
• Pelvic cellulitis
• Respiratory tract infections
• Urinary tract infections
• Febrile neutropenia
• Melioidosis
• Bone and Joint Infections
• G ynecologic Infections
• Biliary tract infections
• Endophthalmitis

Precaution

History of penicillin allergy; severe renal impairment; pregnancy, lactation. Lactation: Drug excreted in breast milk; use with caution

Side Effects

• 1-10% Transient increases in transaminases (3-9%)
• Eosinophilia (<7%)
• Diarrhea (<2%)
• Immune hypersensitivity reaction (2%)
• Phlebitis (<2%)
• Rash (maculopapular or erythematous) (2%)
• Thrombocytosis (2%)
• Injection site pain (1%) <1% Abdominal pain
• Agranulocytosis
• Angioedema
• Asterixis
• Coma
• Dizziness
• Encephalopathy
• Fever
• Hallucinations
• Increased serum concentrations of bilirubin
• Leukopenia
• Lymphocytosis
• Metallic taste
• Myoclonia
• Nausea or vomiting
• Neuromuscular excitability
• Neutropenia
• Paresthesia
• Photosensitivity
• Pruritus
• Seizures
• Thrombocytopenia
• Transient increases in blood urea nitrogen (BUN) or serum creatinine
• Urticaria Potentially Fatal: Anaphylactic reactions
• nephrotoxicity
• pseudomembranous colitis.

Contra indication

Hypersensitivity to cephalosporins.

Pregnancy and lactation

Pregnancy category: B

Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.